Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

New England Journal of Medicine

Volumn 349, Issue 2, 2003, Pages 146-153

  Lee, Agnes Y Y ^a   Levine, Mark N ^a,h   Baker, Ross I ^b   Bowden, Chris ^c   Kakkar, Ajay K ^d   Prins, Martin ^e   Rickles, Frederick R ^f   Julian, Jim A ^a   Math, M ⁱ   Haley, Susan ^a   Kovacs, Michael J ^g   Gent, Michael ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PFIZER INC   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h HENDERSON GENERAL HOSPITAL   (Canada)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN ANTICOAGULANT; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ACENOCOUMAROL; ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; BODY WEIGHT; BRAIN HEMORRHAGE; CANCER; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HEMOPERICARDIUM; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETROPERITONEAL HEMORRHAGE; RISK FACTOR; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME; TUMOR THROMBUS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED; NEOPLASM; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; VEIN THROMBOSIS;

ACENOCOUMAROL; ADMINISTRATION, ORAL; ANTICOAGULANTS; DALTEPARIN; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEOPLASMS; PULMONARY EMBOLISM; RECURRENCE; SURVIVAL ANALYSIS; THROMBOEMBOLISM; VENOUS THROMBOSIS; WARFARIN;

EID: 0037775584     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa025313     Document Type: Article

References (25)

1. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119:Suppl:176S-93S.
2. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR, Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000;18:3078-83.
3. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100:3484-8.
4. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688-98. [Erratum, N Engl J Med 1997;337:1567.]
5. Walsh-McMonagle D, Green D. Low-molecular-weight heparin in the management of Trousseau's syndrome. Cancer 1997;80:649-55.
6. Eikelboom JW, Baker RI. Low-molecular-weight heparin for the treatment of venous thrombosis in patients with adenocarcinoma. Am J Hematol 1998;59:260-1.
7. Luk C, Wells PS, Anderson D, Kovacs MJ. Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy. Am J Med 2001;111:270-3.
8. Lensing AWA, Prandoni P, Brandjes D, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989;320:342-5.
9. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983;98:891-9.
10. Remy-Jardin M, Remy J, Deschildre F, et al. Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 1996; 200:699-706.
11. Qanadli SD, Hajjam ME, Mesurolle B, et al. Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000;217:447-55.
12. Zubrod CG, Schneiderman M, Frei E III, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 1960;11:7-33.
13. Lee AY, Levine MN. Management of venous thromboembolism in cancer patients. Oncology (Huntingt) 2000;14:409-17, 421.
14. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657-62.
15. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Mantel N. Evaluation ofsurvival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-70.
18. Meyer G, Marjanovic Z, Valcke J, et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 2002;162:1729-35.
19. Hull R, Pineo G, Mah A, Brant R. Long-term low molecular weight heparin treatment versus oral anticoagulant therapy for proximal deep vein thrombosis. Blood 2000;96:449a. abstract.
20. Lopaciuk S, Bielska-Falda H, Noszczyk W, et al. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis. Thromb Haemost 1999;81:26-31.
21. Pini M, Aiello S, Manotti C, et al. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost 1994;72:191-7.
22. Velga F, Escriba A, Maluenda MP, et al. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial. Thromb Haemost 2000;84:559-64.
23. Das SK, Cohen AT, Edmondson RA, Melissari E, Kakkar VV. Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial. World J Surg 1996;20:521-6.
24. Gonzalez-Fajardo JA, Arreba E, Castrodeza J, et al. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis. J Vasc Surg 1999;30:283-92.
25. Palareti G, Legnani C, Lee A, et al. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Thromb Haemost 2000;84:805-10.